Skip to main content
Top
Published in: The Egyptian Journal of Neurology, Psychiatry and Neurosurgery 1/2021

Open Access 01-12-2021 | Polyneuropathy | Research

Characteristics of COVID and post COVID polyneuropathies in adults and pediatrics: an Egyptian sample

Authors: Haidy Elshebawy, Mohamed Y. Ezzeldin, Eman Hassan Elzamarany

Published in: The Egyptian Journal of Neurology, Psychiatry and Neurosurgery | Issue 1/2021

Login to get access

Abstract

Background

The aim of this study is to describe the different forms of polyneuropathy associated with coronavirus disease 2019 (COVID-19) as a secondary neurological complication for (COVID-19) and the outcome from different therapeutic regimens in adults and pediatrics in first and second waves of the pandemic.

Case presentation

This study was conducted on 42 patients, they were divided into two groups, group (A) and group (B) in first and second waves respectively. Twenty-five patients presented by ascending weakness preceded by fever, dry cough and respiratory distress, electromyography (EMG) and nerve conduction (NC) studies done and confirmed the clinical diagnosis of demyelinating polyneuropathy. Eight patients presented by acute flaccid quadriparesis, more severe in upper limbs preceded by fever and diarrhea diagnosed as acute axonal polyneuropathy. Five patients presented by severe fatigue and progressive weakness of both lower and upper limbs, they developed fever and cough 10 days after the neurological symptoms. EMG and NC done and confirmed clinical diagnosis of polyneuropathy of demyelinating with secondary axonal picture. Four patients presented 30 to 40 days after their recovery form corona virus infection with gradual progressive weakness of both upper and lower limbs over 2 to 3 months duration, mainly the proximal muscles of lower limbs were affected with areflexia. EMG and NC done and confirmed the diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP).

Conclusion

We should gain a better understanding of the underlying pathophysiology and therapeutic options of polyneuropathies related to COVID-19, which will have an impact on the treatment of the COVID related respiratory failure presenting with neuropathy.
Literature
3.
go back to reference Zhao H, Shen D, Zhou H, Liu J. Guillain–Barré syndrome associated with SARS-CoV-2 infection: causality or coincidence. Lancet Neurol. 2020;19(5):383–4.CrossRefPubMedPubMedCentral Zhao H, Shen D, Zhou H, Liu J. Guillain–Barré syndrome associated with SARS-CoV-2 infection: causality or coincidence. Lancet Neurol. 2020;19(5):383–4.CrossRefPubMedPubMedCentral
7.
8.
go back to reference Jamilloux Y, Henry T, Belot A, Viel S, Fauter M, Jammal T, et al. Should we stimulate or suppress immune responses in COVID-19, cytokine and anticytokine interventions. Autoimmun Rev. 2020;19(7): 102567.CrossRefPubMedPubMedCentral Jamilloux Y, Henry T, Belot A, Viel S, Fauter M, Jammal T, et al. Should we stimulate or suppress immune responses in COVID-19, cytokine and anticytokine interventions. Autoimmun Rev. 2020;19(7): 102567.CrossRefPubMedPubMedCentral
10.
go back to reference Virani A, Rabold E, Hanson T, Haag A, Elrufay R, Chema T, et al. Guillain–Barré Syndrome associated with SARS-CoV-2 infection. IDCases. 2020;20: e00771.CrossRefPubMedPubMedCentral Virani A, Rabold E, Hanson T, Haag A, Elrufay R, Chema T, et al. Guillain–Barré Syndrome associated with SARS-CoV-2 infection. IDCases. 2020;20: e00771.CrossRefPubMedPubMedCentral
11.
go back to reference Yaranagula SD, Koduri VKC. Spectrum of acute neuropathy associated with COVID-19: a clinical and electrophysiological study of 13 patients from a single center. Int J Infect Dis. 2021;110:314–9.CrossRefPubMedPubMedCentral Yaranagula SD, Koduri VKC. Spectrum of acute neuropathy associated with COVID-19: a clinical and electrophysiological study of 13 patients from a single center. Int J Infect Dis. 2021;110:314–9.CrossRefPubMedPubMedCentral
13.
go back to reference da Silva IRF, Frontera JA, Bispo de Filippis AM, Nascimento O. Neurologic complications associated with the zika virus in Brazilian adults. JAMA Neurol. 2017;74(10):1190–8.CrossRefPubMedPubMedCentral da Silva IRF, Frontera JA, Bispo de Filippis AM, Nascimento O. Neurologic complications associated with the zika virus in Brazilian adults. JAMA Neurol. 2017;74(10):1190–8.CrossRefPubMedPubMedCentral
15.
go back to reference El Otmani H, El Moutawakil B, Rafai MA, Benna N, Kettani C, Soussi M, et al. COVID-19 and Guillain–Barré syndrome: more than a coincidence! Rev Neurol. 2020;176(6):518–9.CrossRefPubMed El Otmani H, El Moutawakil B, Rafai MA, Benna N, Kettani C, Soussi M, et al. COVID-19 and Guillain–Barré syndrome: more than a coincidence! Rev Neurol. 2020;176(6):518–9.CrossRefPubMed
16.
go back to reference Camdessanche JP, Morel J, Pozzetto B, Paul S, Tholance Y, Botelho-Nevers E. COVID-19 may induce Guillain–Barré syndrome. Rev Neurol. 2020;176(6):516–8.CrossRefPubMed Camdessanche JP, Morel J, Pozzetto B, Paul S, Tholance Y, Botelho-Nevers E. COVID-19 may induce Guillain–Barré syndrome. Rev Neurol. 2020;176(6):516–8.CrossRefPubMed
18.
go back to reference Padroni M, Mastrangelo V, Asioli GM, Pavolucci L, Rumeileh S, Piscaglia M, et al. Guillain–Barré syndrome following COVID-19: new infection, old complication. J Neurol. 2020;24:1–3. Padroni M, Mastrangelo V, Asioli GM, Pavolucci L, Rumeileh S, Piscaglia M, et al. Guillain–Barré syndrome following COVID-19: new infection, old complication. J Neurol. 2020;24:1–3.
19.
go back to reference Ottaviani D, Boso F, Tranquillini E, Gapeni I, Pedrotti G, Cozzio S, et al. Early Guillain–Barré syndrome in coronavirus disease 2019 (COVID-19): a case report from an Italian COVID-hospital. Neurol Sci. 2020;41(6):1351–4.CrossRefPubMedPubMedCentral Ottaviani D, Boso F, Tranquillini E, Gapeni I, Pedrotti G, Cozzio S, et al. Early Guillain–Barré syndrome in coronavirus disease 2019 (COVID-19): a case report from an Italian COVID-hospital. Neurol Sci. 2020;41(6):1351–4.CrossRefPubMedPubMedCentral
20.
23.
go back to reference Diamanti AP, Rosado MM, Pioli C, Sesti G, Bruno LB. Cytokine release syndrome in COVID-19 patients, a new scenario for an old concern: the fragile balance between infections and autoimmunity. Int J Mol Sci. 2020;21(9):E3330.CrossRef Diamanti AP, Rosado MM, Pioli C, Sesti G, Bruno LB. Cytokine release syndrome in COVID-19 patients, a new scenario for an old concern: the fragile balance between infections and autoimmunity. Int J Mol Sci. 2020;21(9):E3330.CrossRef
Metadata
Title
Characteristics of COVID and post COVID polyneuropathies in adults and pediatrics: an Egyptian sample
Authors
Haidy Elshebawy
Mohamed Y. Ezzeldin
Eman Hassan Elzamarany
Publication date
01-12-2021
Publisher
Springer Berlin Heidelberg
DOI
https://doi.org/10.1186/s41983-021-00435-9

Other articles of this Issue 1/2021

The Egyptian Journal of Neurology, Psychiatry and Neurosurgery 1/2021 Go to the issue